PropertyValue
is ?:annotates of
?:authorAffiliation
  • [\'Cardio-Oncology Program, Division of Cardiovascular Medicine, Department of Medicine, Brigham and Women\'s Hospital, 75 Francis Street, Boston, MA, 02115, USA.\', \'Vascular Medicine Program, Division of Cardiovascular Medicine, Department of Medicine, Lahey Hospital and Medical Center, Burlington, MA, USA.\', \'Cancer Survivorship Program, Division of Hematology Oncology, Department of Medicine, Lahey Hospital and Medical Center, Burlington, MA, USA.\', \'Division of Cardiovascular Medicine, Indiana University Health, Bloomington, IN, USA.\', \'Division of Cardiovascular Medicine, Department of Medicine, Lahey Hospital and Medical Center, Burlington, MA, USA.\', \'Cardio-Oncology Program, Division of Cardiovascular Medicine, Department of Medicine, Lahey Hospital and Medical Center, 41 Mall Road, Burlington, MA, 01805, USA. Sarju.ganatra@lahey.org.\', \'Cardio-Oncology Program, Division of Cardiovascular Medicine, Department of Medicine, Brigham and Women\'s Hospital, 75 Francis Street, Boston, MA, 02115, USA. Anohria@bwh.harvard.edu.\']
?:citedBy
  • -1
?:creator
?:doi
?:doi
  • 10.1007/s11912-021-01070-6
?:hasPublicationType
?:journal
  • Current oncology reports
is ?:pmid of
?:pmid
?:pmid
  • 33937956
?:publication_isRelatedTo_Disease
?:rankingScore_SJR
  • 1.144
?:rankingScore_hIndex
  • 48
is ?:relation_isRelatedTo_publication of
?:title
  • Cardiotoxicity of Immune Checkpoint Inhibitors.
?:type
?:year
  • 2021

Metadata

Anon_0  
expand all